Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2008 3
2009 2
2010 3
2011 1
2013 3
2014 3
2015 3
2016 1
2017 1
2018 2
2020 5
2021 6
2022 5
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer.
Santiago-Sánchez GS, Pita-Grisanti V, Quiñones-Díaz B, Gumpper K, Cruz-Monserrate Z, Vivas-Mejía PE. Santiago-Sánchez GS, et al. Among authors: vivas mejia pe. Int J Mol Sci. 2020 Jun 19;21(12):4365. doi: 10.3390/ijms21124365. Int J Mol Sci. 2020. PMID: 32575507 Free PMC article. Review.
c-MYC and Epithelial Ovarian Cancer.
Reyes-González JM, Vivas-Mejía PE. Reyes-González JM, et al. Among authors: vivas mejia pe. Front Oncol. 2021 Feb 26;11:601512. doi: 10.3389/fonc.2021.601512. eCollection 2021. Front Oncol. 2021. PMID: 33718147 Free PMC article. Review.
ATP11B mediates platinum resistance in ovarian cancer.
Moreno-Smith M, Halder JB, Meltzer PS, Gonda TA, Mangala LS, Rupaimoole R, Lu C, Nagaraja AS, Gharpure KM, Kang Y, Rodriguez-Aguayo C, Vivas-Mejia PE, Zand B, Schmandt R, Wang H, Langley RR, Jennings NB, Ivan C, Coffin JE, Armaiz GN, Bottsford-Miller J, Kim SB, Halleck MS, Hendrix MJ, Bornman W, Bar-Eli M, Lee JS, Siddik ZH, Lopez-Berestein G, Sood AK. Moreno-Smith M, et al. Among authors: vivas mejia pe. J Clin Invest. 2021 Apr 1;131(7):e149893. doi: 10.1172/JCI149893. J Clin Invest. 2021. PMID: 33792569 Free PMC article. No abstract available.
ATP11B mediates platinum resistance in ovarian cancer.
Moreno-Smith M, Halder JB, Meltzer PS, Gonda TA, Mangala LS, Rupaimoole R, Lu C, Nagaraja AS, Gharpure KM, Kang Y, Rodriguez-Aguayo C, Vivas-Mejia PE, Zand B, Schmandt R, Wang H, Langley RR, Jennings NB, Ivan C, Coffin JE, Armaiz GN, Bottsford-Miller J, Kim SB, Halleck MS, Hendrix MJ, Bornman W, Bar-Eli M, Lee JS, Siddik ZH, Lopez-Berestein G, Sood AK. Moreno-Smith M, et al. Among authors: vivas mejia pe. J Clin Invest. 2018 Jul 2;128(7):3199. doi: 10.1172/JCI122301. Epub 2018 May 29. J Clin Invest. 2018. PMID: 29809169 Free PMC article. No abstract available.
MicroRNA-92b targets tumor suppressor gene FBXW7 in glioblastoma.
Grafals-Ruiz N, Sánchez-Álvarez AO, Santana-Rivera Y, Lozada-Delgado EL, Rabelo-Fernandez RJ, Rios-Vicil CI, Valiyeva F, Vivas-Mejia PE. Grafals-Ruiz N, et al. Among authors: vivas mejia pe. Front Oncol. 2023 Sep 11;13:1249649. doi: 10.3389/fonc.2023.1249649. eCollection 2023. Front Oncol. 2023. PMID: 37752997 Free PMC article.
Downstream Effectors of ILK in Cisplatin-Resistant Ovarian Cancer.
Reyes-González JM, Quiñones-Díaz BI, Santana Y, Báez-Vega PM, Soto D, Valiyeva F, Marcos-Martínez MJ, Fernández-de Thomas RJ, Vivas-Mejía PE. Reyes-González JM, et al. Among authors: vivas mejia pe. Cancers (Basel). 2020 Apr 4;12(4):880. doi: 10.3390/cancers12040880. Cancers (Basel). 2020. PMID: 32260415 Free PMC article.
Targeting c-MYC in Platinum-Resistant Ovarian Cancer.
Reyes-González JM, Armaiz-Peña GN, Mangala LS, Valiyeva F, Ivan C, Pradeep S, Echevarría-Vargas IM, Rivera-Reyes A, Sood AK, Vivas-Mejía PE. Reyes-González JM, et al. Among authors: vivas mejia pe. Mol Cancer Ther. 2015 Oct;14(10):2260-9. doi: 10.1158/1535-7163.MCT-14-0801. Epub 2015 Jul 30. Mol Cancer Ther. 2015. PMID: 26227489 Free PMC article.
40 results